These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 14755681

  • 1. Par-4 inducible apoptosis in prostate cancer cells.
    Gurumurthy S, Rangnekar VM.
    J Cell Biochem; 2004 Feb 15; 91(3):504-12. PubMed ID: 14755681
    [Abstract] [Full Text] [Related]

  • 2. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4.
    Qiu G, Ahmed M, Sells SF, Mohiuddin M, Weinstein MH, Rangnekar VM.
    Oncogene; 1999 Jan 21; 18(3):623-31. PubMed ID: 9989812
    [Abstract] [Full Text] [Related]

  • 3. Regulation of cancer cell survival by Par-4.
    Ranganathan P, Rangnekar VM.
    Ann N Y Acad Sci; 2005 Nov 21; 1059():76-85. PubMed ID: 16382046
    [Abstract] [Full Text] [Related]

  • 4. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
    Vetterkind S, Boosen M, Scheidtmann KH, Preuss U.
    Int J Oncol; 2005 Jan 21; 26(1):159-67. PubMed ID: 15586236
    [Abstract] [Full Text] [Related]

  • 5. Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.
    Kukoc-Zivojnov N, Puccetti E, Chow KU, Bergmann M, Ruthardt M, Hoelzer D, Mitrou PS, Weidmann E, Boehrer S.
    Exp Hematol; 2004 Jul 21; 32(7):649-56. PubMed ID: 15246161
    [Abstract] [Full Text] [Related]

  • 6. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells.
    Srinivasan S, Ranga RS, Burikhanov R, Han SS, Chendil D.
    Cancer Res; 2007 Jan 01; 67(1):246-53. PubMed ID: 17185378
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical analysis of the proapoptotic protein Par-4 in normal rat tissues.
    Boghaert ER, Sells SF, Walid AJ, Malone P, Williams NM, Weinstein MH, Strange R, Rangnekar VM.
    Cell Growth Differ; 1997 Aug 01; 8(8):881-90. PubMed ID: 9269897
    [Abstract] [Full Text] [Related]

  • 8. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
    Brieger A, Boehrer S, Schaaf S, Nowak D, Ruthardt M, Kim SZ, Atadja P, Hoelzer D, Mitrou PS, Weidmann E, Chow KU.
    Biochem Pharmacol; 2004 Jul 01; 68(1):85-93. PubMed ID: 15183120
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.
    Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419
    [Abstract] [Full Text] [Related]

  • 10. Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis.
    Bergmann M, Kukoc-Zivojnov N, Chow KU, Trepohl B, Hoelzer D, Weidmann E, Mitrou PS, Boehrer S.
    Ann Hematol; 2004 Oct 15; 83(10):646-53. PubMed ID: 15316756
    [Abstract] [Full Text] [Related]

  • 11. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P, Ma Q, Luo J, Liu B, Tan F, Zhang Z, Chen Z.
    Cancer Invest; 2009 May 15; 27(4):369-75. PubMed ID: 19266349
    [Abstract] [Full Text] [Related]

  • 12. Differential control of apoptosis by DJ-1 in prostate benign and cancer cells.
    Hod Y.
    J Cell Biochem; 2004 Aug 15; 92(6):1221-33. PubMed ID: 15258905
    [Abstract] [Full Text] [Related]

  • 13. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G, Leahy R, Priyadarshini S, Graham K, Delacerda J, Diaz M.
    Int J Oncol; 2004 Mar 15; 24(3):461-71. PubMed ID: 14767530
    [Abstract] [Full Text] [Related]

  • 14. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
    Ye L, Kynaston H, Jiang WG.
    Mol Cancer Res; 2008 Oct 15; 6(10):1594-606. PubMed ID: 18922975
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.
    Li T, Li D, Sha J, Sun P, Huang Y.
    Biochem Biophys Res Commun; 2009 Jun 05; 383(3):280-5. PubMed ID: 19302977
    [Abstract] [Full Text] [Related]

  • 16. Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma.
    Cook J, Krishnan S, Ananth S, Sells SF, Shi Y, Walther MM, Linehan WM, Sukhatme VP, Weinstein MH, Rangnekar VM.
    Oncogene; 1999 Feb 04; 18(5):1205-8. PubMed ID: 10022126
    [Abstract] [Full Text] [Related]

  • 17. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer.
    Zhang X, Jin TG, Yang H, DeWolf WC, Khosravi-Far R, Olumi AF.
    Cancer Res; 2004 Oct 01; 64(19):7086-91. PubMed ID: 15466204
    [Abstract] [Full Text] [Related]

  • 18. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
    Kang J, Bu J, Hao Y, Chen F.
    Prostate Cancer Prostatic Dis; 2005 Oct 01; 8(3):274-9. PubMed ID: 15897917
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mitochondria from TRAIL-resistant prostate cancer cells are capable of responding to apoptotic stimuli.
    Liang Y, Eid MA, Lewis RW, Kumar MV.
    Cell Signal; 2005 Feb 01; 17(2):243-51. PubMed ID: 15494215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.